The main purpose of this proposal is to evaluate the efficacy and safety of a novel food supplement - ACAPHA, in former smokers with bronchial intraepithelial neoplasia (IEN) in a doubleblind, randomized, placebo controlled clinical trial. Bronchial IEN is defined as lesions with a nuclear morphometry index greater than 1.36 and a histopathology grade of metaplasia/worse. 2088 former smokers (greater than or equal to 30 pack-years) will be screened with image analysis of sputum cells over a three year period. Ninety subjects with one or more IEN lesions autofluorescence bronchoscopy and biopsy will receive ACAPHA/Placebo for 6 months. The unique features of this proposal are: (1) an experienced clinical trial team with a proven track record of completing several consecutive NCI sponsored chemoprevention trials on schedule, (2) a unique sputum induction method combining high frequency chest wall oscillation and 3% saline nebulization that can reduce unsatisfactory sputum samples rate to less than 3%, (3) a sputum cell image analysis method that can reduce the number of unproductive bronchoscopies by over 50%, (4) a newly developed quantitative autofluorescence bronchoscopy method that can localize IEN lesions with high sensitivity as well as to measure their size, (5) enrollment of subjects with large IEN lesions to reduce the false regression rate on re-biopsy after treatment, (6) a novel chemopreventive agent that is a food supplement with remarkable efficacy and demonstrated safety for more than 26 years, (7) the use of an electronic database of bronchial biopsy images to aid consensus diagnoses and evaluation of responses, (8) the addition of nuclear morphometry as an adjunct to histopathology in bronchial biopsies as the primary endpoint for efficacy assessment, (9) a major new initiative to develop confocal microendoscopy as a non-biopsy method to assess the effect of chemopreventive agents, and (10) testing of novel biomarkers approaches such as quantitative methylation in sputa and BAL cells. The results will provide new information on the efficacy and safety of a novel botanical food supplement for chemoprevention of lung cancer. It will also provide new information on the use of novel biomarkers as surrogate endpoints for assessing the effect of chemoprevention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01CA096109-01
Application #
6482758
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (J3))
Program Officer
Szabo, Eva
Project Start
2002-09-17
Project End
2007-08-31
Budget Start
2002-09-17
Budget End
2003-08-31
Support Year
1
Fiscal Year
2002
Total Cost
$1,042,339
Indirect Cost
Name
British Columbia Cancer Agency
Department
Type
DUNS #
209137736
City
Vancouver
State
BC
Country
Canada
Zip Code
V5 1-L3
McWilliams, Annette; Tammemagi, Martin C; Mayo, John R et al. (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369:910-9
Steiling, Katrina; van den Berge, Maarten; Hijazi, Kahkeshan et al. (2013) A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med 187:933-42
Li, Gerald; Guillaud, Martial; LeRiche, Jean et al. (2012) Automated sputum cytometry for detection of intraepithelial neoplasias in the lung. Anal Cell Pathol (Amst) 35:187-201
Yee, John; Sadar, Marianne D; Sin, Don D et al. (2009) Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol 27:2787-92
Lane, Pierre M; Lam, Stephen; McWilliams, Annette et al. (2009) Confocal fluorescence microendoscopy of bronchial epithelium. J Biomed Opt 14:024008
Lane, Pierre M; MacAulay, Calum E (2009) Reflection-contrast limit of fiber-optic image guides. J Biomed Opt 14:064028
Gao, Guanghua; Law, Francis C P (2009) Physiologically based pharmacokinetics of matrine in the rat after oral administration of pure chemical and ACAPHA. Drug Metab Dispos 37:884-91
Yuan, R; Hogg, J C; Paré, P D et al. (2009) Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography. Thorax 64:944-9
Sheel, A William; Guenette, Jordan A; Yuan, Ren et al. (2009) Evidence for dysanapsis using computed tomographic imaging of the airways in older ex-smokers. J Appl Physiol (1985) 107:1622-8
Lam, Stephen; Standish, Beau; Baldwin, Corisande et al. (2008) In vivo optical coherence tomography imaging of preinvasive bronchial lesions. Clin Cancer Res 14:2006-11

Showing the most recent 10 out of 18 publications